Courts debate on PMS related rebate provision

A controversy surrounding the different rulings of the postmarketing surveillance (PMS) by a High or Supreme Court is growing.

Doctors and patients expect that when medications are prescribed correctly for labeled indications and are used as directed, these medications generally will have beneficial effects and will not cause significant harm. This confidence in pharmaceutical products refle...